Articles about ACRES

Update on testing ACRES quality standard for clinical research sites

ACRES begins testing quality standard for clinical research sites 16-Oct-2018 By Melissa Fassbender Teams have initiated validation of the global quality standard and procedure testing for the voluntary accreditation of clinical research sites. HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2018/10/16/ACRES-BEGINS-TESTING-QUALITY-STANDARD-FOR-CLINICAL-RESEARCH-SITES    

NEJM: Accreditation of Clinical Research Sites — Moving Forward

Perspective Accreditation of Clinical Research Sites — Moving Forward NEJM 27 June 2018 Greg Koski, Ph.D., M.D., Larry Kennedy, Ph.D., Mary F. Tobin, Ph.D. and Matthew Whalen, Ph.D. ARTICLE Metrics 5 References Accreditation is used in many fields, including education, travel, construction, and health care. When implemented correctly, it improves quality, performance, and safety, while signaling to the…

HealthCarePoint Successfully Completes Global Testing on BlueCloud 2.0 Networking Technology

BlueCloud® 2.0 is enabling industry stakeholders to develop dozens of new business models that reduce costs while improving patient care. “We are witnessing the emergence of a new paradigm in which healthcare and research are coming together as never before” AUSTIN, TEXAS (PRWEB) MARCH 29, 2016 HealthCarePoint (HCP), a Texas-based healthcare and clinical research networking-technology company founded…

ACRES and HealthCarePoint Collaborate Through BlueCloud

Clinical Informatics News By Ann Neuer March 11, 2015 | The Alliance for Clinical Research Excellence and Safety—ACRES—has announced a collaboration with HealthCarePoint, a healthcare and clinical research networking technology provider and one of ACRES’ strategic allies, to launch ACRES BlueCloud, an integration platform for parties across the global clinical research enterprise. Through a multi-million dollar…

A Global Systems for Clinical Research

Magazine Article | September 2, 2014 By Fred Olds, contributing editor Life Sciences Leader “It would be an enormous benefit to pharma and humanity if we had a more efficient and systematic way to bring safe and effective drugs to market,” says Greg Koski Ph.D., M.D., CEO, president and cofounder of the Alliance for Clinical…